Bicocca Open Archive

Logo unimib boa
VETTORETTI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 345
EU - Europa 313
NA - Nord America 176
SA - Sud America 4
AF - Africa 2
Totale 840
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 240
RU - Federazione Russa 185
US - Stati Uniti d'America 162
SG - Singapore 72
DE - Germania 70
CN - Cina 28
IT - Italia 19
NL - Olanda 12
MX - Messico 11
FR - Francia 5
UA - Ucraina 5
FI - Finlandia 4
GB - Regno Unito 4
SE - Svezia 3
AT - Austria 2
BR - Brasile 2
CA - Canada 2
IE - Irlanda 2
MM - Myanmar 2
ZA - Sudafrica 2
AR - Argentina 1
EC - Ecuador 1
HU - Ungheria 1
KG - Kirghizistan 1
LK - Sri Lanka 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
Totale 840
Salva come PNG Salva come JPEG
Città #
Hong Kong 240
Frankfurt am Main 43
Ann Arbor 37
Singapore 29
Moscow 15
Ashburn 14
Mexico City 10
Wenzhou 10
Xiamen 10
Seattle 8
Chandler 7
Buffalo 6
Cambridge 6
Fairfield 6
Ningbo 6
Santa Clara 6
Haarlem 5
Wilmington 5
Düsseldorf 4
Los Angeles 4
Milan 4
New York 4
Woodbridge 4
Amsterdam 3
Helsinki 3
Mazara del Vallo 3
Boydton 2
Bronte 2
Dublin 2
Houston 2
Lauterbourg 2
Nuremberg 2
Parma 2
Princeton 2
Slough 2
Yangon 2
Bishkek 1
Cinisello Balsamo 1
Colombo 1
Croydon 1
Halifax 1
Lawrence 1
Lisbon 1
London 1
Manila 1
Monza 1
Olímpia 1
Phoenix 1
Quito 1
Rome 1
Río Cuarto 1
Sopron 1
São Paulo 1
Wuhan 1
Totale 530
Salva come PNG Salva come JPEG
Nome #
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 193
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 32
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 27
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy (Journal of Nephrology, (2023), 36, 7, (2013-2022), 10.1007/s40620-023-01708-7) 23
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 19
What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives 19
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 18
Vulvar pyoderma gangrenosum with renal involvement 18
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 17
Economic evaluation of angiotensin receptor blockers in type 2 diabetes, hypertension, and nephropathy 16
Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: A pilot study 16
Endothelial dysfunction in chronic kidney disease: Determinant of susceptibility to end-organ damage and therapeutic response 15
Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction 15
Frailty Is Associated with Malnutrition–Inflammation Syndrome in Older CKD Patients 15
Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease 14
Relationship between number of daily exchanges at CAPD start with clinical outcomes 14
What's New in the CKD-BMD Therapy? 14
Peritoneal dialysis related peritonitis: insights from a long-term analysis of an Italian center 14
Plasma adiponectin levels in chronic kidney disease patients: Relation with molecular inflammatory profile and metabolic status 14
Spontaneous low-protein intake in older CKD patients: one diet may not fit all 13
Clinical Factors and Biomarkers Associated with Depressive Disorders in Older Patients Affected by Chronic Kidney Disease (CKD): Does the Advanced Glycation End Products (AGEs)/RAGE (Receptor for AGEs) System Play Any Role? 13
Palliative and Supportive Dialysis: Current Practices and Recommendations for Best Clinical Practice 13
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: An Italian multicenter prospective study 13
Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease 13
Poor Nutritional Status Is Associated with Death in a Population of Dialyzed Older Persons 13
Palliative and supportive dialysis: State of the art and recommendations for good clinical practice 13
Pulse pressure and subclinical cardiovascular damage in primary hypertension 13
Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation 13
Corrigendum: Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study (Frontiers in Medicine, (2023), 10, (1221086), 10.3389/fmed.2023.1221086) 12
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 11
Microalbuminuria, cardiovascular, and renal risk in primary hypertension 11
Simultaneous removal and replacement of the peritoneal catheter in CAPD patient with refractory peritonitis sustained by P. aeruginosa: A case-report 11
Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation 10
The role of angiotensin II AT1 receptor antagonists in nephroprotection and cardioprotection in type 2 diabetes mellitus 9
Creatinine clearance and signs of end-organ damage in primary hypertension 9
Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats 9
Vitamin D and subclinical cardiac damage in a cohort of kidney transplanted patients: a retrospective observational study 9
Mild renal dysfunction and renal vascular resistance in primary hypertension 9
Prevention and treatment of diabetic nephropathy: The program for Irbesartan mortality and morbidity evaluation 9
Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study 9
Optimizing global risk evaluation in primary hypertension: The role of microalbuminuria and cardiovascular ultrasonography 9
Cardiovascular and Renal Risk Assessment as a Guide for Treatment in Primary Hypertension 9
MCP1 Inverts the Correlation between FGF23 and Omega 6/3 Ratio: Is It Also True in Renal Transplantation? 9
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: An artificial neural network-based approach 9
Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study 9
Association between the uremic toxins indoxyl-sulfate and p-cresyl-sulfate with sarcopenia and malnutrition in elderly patients with advanced chronic kidney disease 8
Use of the Frailty Index in Older Persons With Chronic Kidney Disease 8
Patients with Hypertensive Nephropathy and Chronic Kidney Disease Might Not Benefit from Strict Blood Pressure Control 8
Can Mediterranean Diet Have a Positive Impact on Kidney Health? A Pending Answer to a Long-Time Question 8
Is there an association between severity of illness and psychiatric symptoms in patients with chronic renal failure? 8
Beyond cohort selection: An analytics-enabled i2b2 8
Possible Benefits of a Low Protein Diet in Older Patients With CKD at Risk of Malnutrition: A Pilot Randomized Controlled Trial 8
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension 8
Renal and cardiovascular protection in type 2 diabetes mellitus: Angiotensin II receptor blockers 8
Advanced glycation end products (Age) and soluble forms of age receptor: Emerging role as mortality risk factors in CKD 8
Mild Renal Dysfunction and Cardiovascular Risk in Hypertensive Patients 8
Importance of blood pressure control in chronic kidney disease 8
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 8
Associations Between Cholesterol and Fatty Acid Profile on the Severity of Depression in Older Persons With Nondialysis Chronic Kidney Disease 8
Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress 8
Serum uric acid and target organ damage in primary hypertension 8
The Number of Medications Is Associated with Fractures in a Population of Dialyzed Older Patients with Frailty 8
The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism 8
Treatment of hyperuricemia in CKD 8
MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKD 8
Changes over time in ambulatory blood pressure and cardiac parameters predict cardiovascular outcome of patients with CKD and low cardiovascular morbidity 8
Renal endothelial function is associated with the anti-proteinuric effect of ACE inhibition in 5/6 nephrectomized rats 8
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 8
Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship 8
Metabolic acidosis in renal transplantation: neglected but of potential clinical relevance 7
In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition 7
Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress 7
Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice 7
Frailty in kidney transplantation: a review on its evaluation, variation and long-term impact 7
Calcium carbonate-enriched cheese to improve nutrition, compliance and phosphorus control in patients on kidney replacement therapy 7
Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension 7
Frailty index and adverse outcomes in older patients in haemodialysis 7
Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension 7
Frailty phenotype and multi-domain impairments in older patients with chronic kidney disease 7
Sarcopenia is associated with malnutrition but not with systemic inflammation in older persons with advanced CKD 7
Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease 7
AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease 7
Nutritional Strategies to Prevent Muscle Loss and Sarcopenia in Chronic Kidney Disease: What Do We Currently Know? 7
A new CHA2DS2VASC score integrated with estimated glomerular filtration rate, left ventricular hypertrophy, and pulse pressure is highly effective in predicting adverse cardiovascular outcome in chronic kidney disease 6
Malnutrition and inflammation are associated with severity of depressive and cognitive symptoms of old patients affected by chronic kidney disease 6
Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease 6
Totale 1.101
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 38 1 6 4 5 5
2021/202232 5 8 6 2 1 5 0 0 2 0 1 2
2022/202357 5 14 9 8 9 7 0 0 2 1 0 2
2023/202414 1 2 2 1 0 5 0 0 2 0 0 1
2024/2025939 1 6 2 2 3 1 15 4 558 347 0 0
Totale 1.101